| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Nicole Gerwin | |
| Andrea Lucke | |||
| Caroline Hops | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 226-242 | |
| P577 | publication date | 2006-02-23 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Intraarticular drug delivery in osteoarthritis | |
| P478 | volume | 58 |
| Q38978728 | A cost analysis of the establishment of a dedicated orthopaedic outpatient injection clinic at a single institution |
| Q90166253 | A placebo-controlled study comparing the efficacy of intra-articular injections of hyaluronic acid and a novel hyaluronic acid-platelet-rich plasma conjugate in a canine model of osteoarthritis |
| Q33807290 | Additive effects of intra-articular injection of growth hormone and hyaluronic acid in rabbit model of collagenase-induced osteoarthritis |
| Q35295915 | Administration of substances to laboratory animals: routes of administration and factors to consider. |
| Q89795279 | Amniotic Product Treatments: Clinical and Basic Science Evidence |
| Q59101195 | Application of liposomes in treatment of rheumatoid arthritis: quo vadis |
| Q39376032 | Appropriate Use Criteria for Hyaluronic Acid in the Treatment of Knee Osteoarthritis in the United States |
| Q41958163 | Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis |
| Q42181689 | Biocompatibility assessment of novel collagen-sericin scaffolds improved with hyaluronic Acid and chondroitin sulfate for cartilage regeneration. |
| Q35380390 | Biomechanical influence of cartilage homeostasis in health and disease |
| Q50850633 | Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models. |
| Q36567581 | Biomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo model |
| Q88873051 | Cartilage diseases |
| Q39137486 | Cartilage-targeting drug delivery: can electrostatic interactions help? |
| Q36010323 | Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint |
| Q33552879 | Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants |
| Q41525275 | Charge based intra-cartilage delivery of single dose dexamethasone using Avidin nano-carriers suppresses cytokine-induced catabolism long term |
| Q33765435 | Chronic oral or intraarticular administration of docosahexaenoic acid reduces nociception and knee edema and improves functional outcomes in a mouse model of Complete Freund's Adjuvant-induced knee arthritis |
| Q43849342 | Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery |
| Q54484961 | Combination of MEK-ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment. |
| Q90177398 | Combined Experimental Approach and Finite Element Modeling of Small Molecule Transport Through Joint Synovium to Measure Effective Diffusivity |
| Q33765081 | Comparison of piroxicam pharmacokinetics and anti-inflammatory effect in rats after intra-articular and intramuscular administration |
| Q38069892 | Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems |
| Q35690247 | Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation |
| Q49158253 | Delivering rhFGF-18 via a bilayer collagen membrane to enhance microfracture treatment of chondral defects in a large animal model. |
| Q92255648 | Design and Biological Evaluation of Colchicine-CD44-Targeted Peptide Conjugate in an In Vitro Model of Crystal Induced Inflammation |
| Q92730600 | Design and In Vivo Pharmacokinetic Evaluation of Triamcinolone Acetonide Microcrystals-Loaded PLGA Microsphere for Increased Drug Retention in Knees after Intra-Articular Injection |
| Q41978991 | Design of methylprednisolone biodegradable microspheres intended for intra-articular administration |
| Q37059377 | Detection of calcium phosphate crystals in the joint fluid of patients with osteoarthritis - analytical approaches and challenges |
| Q36825938 | Dexamethasone Release from Within Engineered Cartilage as a Chondroprotective Strategy Against Interleukin-1α. |
| Q92574594 | Diclofenac Prodrugs for Intra-articular Depot Injectables: In Vitro Hydrolysis and Species Variation |
| Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
| Q40267892 | Diffusion of mepivacaine to adjacent synovial structures after intrasynovial analgesia of the digital flexor tendon sheath. |
| Q38168885 | Drug delivery systems for intra-articular treatment of osteoarthritis |
| Q35861394 | Effects of corticosteroids and their combinations with hyaluronanon on the biochemical properties of porcine cartilage explants |
| Q35840719 | Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines |
| Q53569196 | Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints. |
| Q37242946 | Emerging intra-articular drug delivery systems for the temporomandibular joint. |
| Q33634515 | Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model |
| Q35617606 | Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain |
| Q41904451 | Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. |
| Q37268084 | Formulation of topical bioadhesive gel of aceclofenac using 3-level factorial design |
| Q38030641 | From nano- to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering |
| Q51253381 | Functional Recovery in Osteoarthritic Chondrocytes Through Hyaluronic Acid and Platelet-Rich Plasma-Inhibited Infrapatellar Fat Pad Adipocytes. |
| Q59359723 | Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model |
| Q58830266 | Glucan particles loaded with a NIRF agent for imaging monocytes/macrophages recruitment in a mouse model of rheumatoid arthritis |
| Q37225595 | Hyaluronic acid-coated bovine serum albumin nanoparticles loaded with brucine as selective nanovectors for intra-articular injection |
| Q95851894 | In Situ Hydrogel Formulation for Intra-Articular Application of Diclofenac Sodium-Loaded Polymeric Nanoparticles |
| Q51562996 | In vitro release and In vivo biocompatibility studies of biomimetic multilayered alginate-chitosan/β-TCP scaffold for osteochondral tissue. |
| Q37426867 | Increased localized delivery of piroxicam by cationic nanoparticles after intra-articular injection |
| Q36057665 | Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches |
| Q38261368 | Inhibition of aggrecanases as a therapeutic strategy in osteoarthritis. |
| Q92557351 | Injectable mechanical pillows for attenuation of load-induced post-traumatic osteoarthritis |
| Q40840955 | Intra-articular Duration of Durolane™ after Single Injection into the Rabbit Knee |
| Q88906071 | Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints |
| Q56334565 | Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation |
| Q97527844 | Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis |
| Q89909814 | Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis |
| Q37800272 | Intra-articular drug delivery: The challenge to extend drug residence time within the joint |
| Q38649059 | Intra-articular injection of micronized dehydrated human amnion/chorion membrane attenuates osteoarthritis development. |
| Q38823835 | Intra-articular therapies for osteoarthritis |
| Q93377427 | Intra-articular treatment options for knee osteoarthritis |
| Q33891966 | Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis |
| Q39165523 | Liposomal formulation of chondroitin sulfate enhances its antioxidant and anti-inflammatory potential in L929 fibroblast cell line. |
| Q80387959 | Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes |
| Q50601658 | Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension. |
| Q60935428 | Mechanistic insight into hyaluronic acid and platelet-rich plasma-mediated anti-inflammatory and anti-apoptotic activities in osteoarthritic mice |
| Q89095335 | Molecular transport in articular cartilage - what have we learned from the past 50 years? |
| Q60245572 | Multifunctional Carrier Based on Halloysite/Laponite Hybrid Hydrogel for Kartogenin Delivery |
| Q58910462 | Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs |
| Q37789181 | Nanotechnology and its Relationship to Interventional Radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention |
| Q37564501 | Nanotechnology controlled drug delivery for treating bone diseases |
| Q44363099 | New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases |
| Q37729031 | Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee |
| Q37950849 | Non-surgical management of early knee osteoarthritis |
| Q36758384 | Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models |
| Q46110988 | Novel protein therapeutic joint retention strategy based on collagen-binding Avimers |
| Q52741561 | Optimisation of platelet concentrates therapy: Composition, localisation, and duration of action. |
| Q36303687 | Particle-based technologies for osteoarthritis detection and therapy |
| Q36857699 | Particles for Local Delivery of Proteins Using Intra-Articular Route |
| Q92628601 | Perspective on Intra-articular Injection Cell Therapy for Osteoarthritis Treatment |
| Q42050959 | Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion |
| Q35868349 | Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration |
| Q45872452 | Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy |
| Q35216247 | Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes |
| Q80764948 | Polymer therapeutics: reservoir drugs |
| Q85183242 | Predictive factors of hyaluronic acid injections short-term effectiveness for TMJ degenerative joint disease |
| Q95360919 | Role of Intra-articular Platelet Rich Plasma in the Management of Osteoarthritis: A Review |
| Q35200825 | Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial |
| Q97425810 | Studies of nanoparticle delivery with in vitro bio-engineered microtissues |
| Q46485316 | Sucrose, But Not Glucose, Blocks IL1-β-Induced Inflammatory Response in Human Chondrocytes by Inducing Autophagy via AKT/mTOR Pathway |
| Q47915082 | Surgical suture releasing macrophage-targeted drug-loaded nanoparticles for an enhanced anti-inflammatory effect. |
| Q40353957 | Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery |
| Q51598564 | Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis. |
| Q50851448 | Synthetic nanoscale electrostatic particles as growth factor carriers for cartilage repair. |
| Q37163015 | Technology insight: adult mesenchymal stem cells for osteoarthritis therapy |
| Q39934139 | The pharmacokinetics of the weakly protein-bound anionic compound diatrizoate in serum and synovial fluid of the horse |
| Q41822271 | The role of miR-320a and IL-1β in human chondrocyte degradation |
| Q44375381 | Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation. |
| Q36681123 | Transport of anti-IL-6 antigen binding fragments into cartilage and the effects of injury |
| Q38079921 | Viscosupplementation in patients with osteoarthritis of the knee |
| Q95446216 | siRNA-based therapeutic approaches for rheumatic diseases |
| Q58537367 | visualization of osteoarthritic hypertrophic lesions |
| Q34147976 | β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release |
Search more.